Cravath’s London Office Moves to 100 Cheapside
Andrew M. Wark focuses his practice on public and private mergers and acquisitions, shareholder activism defense and general corporate matters. Mr. Wark’s clients have included AXA, Barrick Gold, Benchmark Electronics, CardWorks, Convey Health Solutions, Corteva, Cox Enterprises, Crown Castle, Eurazeo, Fortress Transportation & Infrastructure Investors, FS Investments, GuideWell, IBM, Just Eat Takeaway.com, Olin, Peabody Energy, RELX Group, Sensata Technologies, Viatris and ViewRay.
Mr. Wark’s notable M&A transactions include representing:
- Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
- CardWorks in its acquisition of Ally’s credit card business;
- Just Eat Takeaway.com in the sale of Grubhub to Wonder;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
-
Viatris in its divestitures totaling $3.6 billion in value, including the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses;
-
Viatris in its $750 million acquisitions of Oyster Point and Famy Life Sciences;
- Newcrest in its A$28.8 billion acquisition by Newmont;
- FS Investments in its combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
- Cowen in its $1.9 billion acquisition by TD;
- Convey Health Solutions in its $1.1 billion take‑private acquisition by TPG Capital;
- GuideWell in its $900 million combination with Triple-S Management;
- The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;
- Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;
- Barrick Gold in its proposed $42 billion merger and subsequent joint venture with Newmont Mining and its $18.3 billion merger with Randgold Resources;
- RELX Group in its acquisition of Emailage;
- Peabody Energy in its proposed joint venture with Arch Resources;
- AXA in its $15.3 billion acquisition of XL;
- Cincinnati Bell in its $650 million combination with Hawaiian Telcom and its $201 million acquisition of OnX Enterprise Solutions;
- Eurazeo in its majority investment in WorldStrides;
- Crown Castle in its $7.1 billion acquisition of Lightower and its $1.5 billion acquisition of FiberNet;
- Alere in its $8 billion sale to Abbott Laboratories;
- MarkWest Energy Partners in its $21 billion merger with MPLX;
- IBM in its acquisition of Clearleap; and
- Olin in its $5 billion Reverse Morris Trust acquisition of the chlorine value chain business of Dow Chemical.
Mr. Wark has also represented numerous companies and boards of directors regarding shareholder activism, including representing Benchmark Electronics in its cooperation agreement with Engaged Capital, Corteva in its agreement with Starboard, Sensata Technologies in its cooperation agreement with Elliott Management and ViewRay in its cooperation agreement with Hudson Executive Capital.
Mr. Wark was named an M&A “Rising Star” by The Deal in 2021 and has been recognized by Lawdragon as among the “500 Leading Dealmakers in America” and the “500 X – The Next Generation.” He also co‑authored the United States chapter of “Getting the Deal Through: Distressed M&A.”
Mr. Wark was born in Portland, Oregon. He received a B.S. from Duke University in 2010 and a J.D. from Columbia Law School in 2013, where he was a Harlan Fiske Stone Scholar and a Staff Editor of the Law Review.
Mr. Wark joined Cravath in 2013 and was elected a partner in 2020.
Mr. Wark’s notable M&A transactions include representing:
- Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
- CardWorks in its acquisition of Ally’s credit card business;
- Just Eat Takeaway.com in the sale of Grubhub to Wonder;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
-
Viatris in its divestitures totaling $3.6 billion in value, including the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses;
-
Viatris in its $750 million acquisitions of Oyster Point and Famy Life Sciences;
- Newcrest in its A$28.8 billion acquisition by Newmont;
- FS Investments in its combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
- Cowen in its $1.9 billion acquisition by TD;
- Convey Health Solutions in its $1.1 billion take‑private acquisition by TPG Capital;
- GuideWell in its $900 million combination with Triple-S Management;
- The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;
- Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;
- Barrick Gold in its proposed $42 billion merger and subsequent joint venture with Newmont Mining and its $18.3 billion merger with Randgold Resources;
- RELX Group in its acquisition of Emailage;
- Peabody Energy in its proposed joint venture with Arch Resources;
- AXA in its $15.3 billion acquisition of XL;
- Cincinnati Bell in its $650 million combination with Hawaiian Telcom and its $201 million acquisition of OnX Enterprise Solutions;
- Eurazeo in its majority investment in WorldStrides;
- Crown Castle in its $7.1 billion acquisition of Lightower and its $1.5 billion acquisition of FiberNet;
- Alere in its $8 billion sale to Abbott Laboratories;
- MarkWest Energy Partners in its $21 billion merger with MPLX;
- IBM in its acquisition of Clearleap; and
- Olin in its $5 billion Reverse Morris Trust acquisition of the chlorine value chain business of Dow Chemical.
Mr. Wark has also represented numerous companies and boards of directors regarding shareholder activism, including representing Benchmark Electronics in its cooperation agreement with Engaged Capital, Corteva in its agreement with Starboard, Sensata Technologies in its cooperation agreement with Elliott Management and ViewRay in its cooperation agreement with Hudson Executive Capital.
Mr. Wark was named an M&A “Rising Star” by The Deal in 2021 and has been recognized by Lawdragon as among the “500 Leading Dealmakers in America” and the “500 X – The Next Generation.” He also co‑authored the United States chapter of “Getting the Deal Through: Distressed M&A.”
Mr. Wark was born in Portland, Oregon. He received a B.S. from Duke University in 2010 and a J.D. from Columbia Law School in 2013, where he was a Harlan Fiske Stone Scholar and a Staff Editor of the Law Review.
Mr. Wark joined Cravath in 2013 and was elected a partner in 2020.
Education
- J.D., 2013, Columbia Law SchoolHarlan Fiske Stone Scholar
- B.S., 2010, Duke University
Admitted In
- New York
Rankings
The Dealmaker Quarterly
- Rising Star (2021)
Lawdragon
- 500 Leading Dealmakers in America (2024, 2023)
- 500 X – The Next Generation (2024, 2023)
Deals & Cases
January 28, 2025
Paragon 28’s $1.2 Billion Acquisition by Zimmer Biomet
On January 28, 2025, Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused on the foot and ankle orthopedic segment, and Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”), a global medical technology leader, announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. Cravath is representing Paragon 28 in connection with the transaction.
Deals & Cases
January 22, 2025
CardWorks’s Acquisition of Ally’s Credit Card Business
On January 22, 2025, CardWorks, Inc. (“CardWorks”), a leader in credit and payments, and Ally Financial Inc. (“Ally”), a financial services company with the nation’s largest all‑digital bank and an industry‑leading auto financing business, announced that they have entered into a definitive agreement for CardWorks, and its wholly‑owned bank subsidiary, Merrick Bank, to acquire Ally’s credit card business, including a portfolio of $2.3 billion in credit card receivables with 1.3 million active cardholders as of December 31, 2024. Cravath is representing CardWorks in connection with the transaction.
Deals & Cases
November 13, 2024
Just Eat Takeaway.com’s Sale of Grubhub to Wonder
On November 13, 2024, Just Eat Takeaway.com N.V. (“Just Eat Takeaway.com”), one of the world’s leading global online food delivery companies, announced that it has entered into a definitive agreement to sell Grubhub Inc. (“Grubhub”) to Wonder Group, Inc. (“Wonder”) for an enterprise value of $650 million. Grubhub will be transferred with its $500 million of senior notes. Cravath is representing Just Eat Takeaway.com in connection with the transaction.
Deals & Cases
July 16, 2024
Atalaya Capital Management’s Sale of its Business to Blue Owl Capital
On July 16, 2024, Atalaya Capital Management LP (“Atalaya Capital Management”), a privately‑held alternative credit manager, and Blue Owl Capital Inc. (“Blue Owl Capital”), an alternative asset manager, announced that they have entered into a definitive agreement for Blue Owl Capital to acquire the business of Atalaya Capital Management for $450 million. The closing purchase price of $450 million is comprised of $350 million of Blue Owl equity and $100 million of cash. In addition, there is potential for up to $350 million of earnout consideration in the form of equity, subject to certain adjustments and achievement of future revenue targets. Cravath is representing Atalaya Capital Management in connection with the transaction.
Deals & Cases
April 30, 2024
Sensata Technologies’ Cooperation Agreement with Elliott
On April 29, 2024, Sensata Technologies Holding plc (“Sensata Technologies”), a global industrial technology company, announced that it has entered into a Cooperation Agreement with Elliott Investment Management L.P. (“Elliott”). The Cooperation Agreement contains customary standstill, voting and other provisions. Cravath is representing Sensata Technologies in connection with the agreement.
Activities
June 12, 2024
Three Cravath Partners Featured in Vault’s 2024 Guide to Legal Practice Areas
Cravath partners Helam Gebremariam, Evan Norris and Andrew M. Wark were featured in the 2024 edition of “Practice Perspectives: Vault’s Guide to Legal Practice Areas,” which highlights the experiences of practicing lawyers in more than 20 different areas of the law and is published annually.
Publications
October 24, 2023
SEC Adopts Rule Amendments To Modernize Beneficial Ownership Reporting
On October 20, 2023, Cravath prepared a memo for its clients entitled “SEC Adopts Rule Amendments To Modernize Beneficial Ownership Reporting.” The memo examines the U.S. Securities and Exchange Commission’s recently adopted final rule amendments to modernize beneficial ownership reporting under Sections 13(d) and 13(g) of the Securities Exchange Act of 1934. The memo outlines the final rule amendments’ changes and guidance related to deadlines and cut‑off times for Schedule 13D and Schedule 13G filings, structured data language, the application of Regulation 13D-G to certain derivative securities and the definition of “group” in existing statutory language.
Publications
March 17, 2023
Andrew Wark and Maggie Segall Author Chapter on U.S. Antitrust Enforcement Trends in Deal‑Making for the International Comparative Legal Guide’s “Mergers & Acquisitions 2023”
Cravath partners Andrew M. Wark and Margaret T. Segall authored a chapter for the International Comparative Legal Guide’s “Mergers & Acquisitions 2023,” which provides cross border insights into mergers and acquisitions and was published by Global Legal Group on March 16, 2023. The chapter, entitled “Key Drivers and Trends: Deal‑Making in an Era of Heightened Antitrust Enforcement,” examines how companies considering M&A transactions in the United States have faced an evolving antitrust landscape, including changed enforcement practices and merger review procedures.
Publications
December 01, 2022
Jed Zobitz, Paul Zumbro and Andrew Wark Co‑Author U.S. Chapter of Lexology Getting The Deal Through’s “Distressed M&A 2023”
Cravath partners George E. Zobitz, Paul H. Zumbro and Andrew M. Wark co‑authored the United States chapter of Lexology Getting The Deal Through’s “Distressed M&A 2023,” which was published in November 2022. The chapter surveys the current market climate and legal framework for distressed M&A and provides a comprehensive overview of these transactions. The authors address relevant considerations involving transaction structures and sale process, due diligence, valuation and financing, documentation, regulatory and judicial approvals, and dispute resolution.
Andrew M. Wark focuses his practice on public and private mergers and acquisitions, shareholder activism defense and general corporate matters. Mr. Wark’s clients have included AXA, Barrick Gold, Benchmark Electronics, CardWorks, Convey Health Solutions, Corteva, Cox Enterprises, Crown Castle, Eurazeo, Fortress Transportation & Infrastructure Investors, FS Investments, GuideWell, IBM, Just Eat Takeaway.com, Olin, Peabody Energy, RELX Group, Sensata Technologies, Viatris and ViewRay.
Mr. Wark’s notable M&A transactions include representing:
- Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
- CardWorks in its acquisition of Ally’s credit card business;
- Just Eat Takeaway.com in the sale of Grubhub to Wonder;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
-
Viatris in its divestitures totaling $3.6 billion in value, including the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses;
-
Viatris in its $750 million acquisitions of Oyster Point and Famy Life Sciences;
- Newcrest in its A$28.8 billion acquisition by Newmont;
- FS Investments in its combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
- Cowen in its $1.9 billion acquisition by TD;
- Convey Health Solutions in its $1.1 billion take‑private acquisition by TPG Capital;
- GuideWell in its $900 million combination with Triple-S Management;
- The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;
- Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;
- Barrick Gold in its proposed $42 billion merger and subsequent joint venture with Newmont Mining and its $18.3 billion merger with Randgold Resources;
- RELX Group in its acquisition of Emailage;
- Peabody Energy in its proposed joint venture with Arch Resources;
- AXA in its $15.3 billion acquisition of XL;
- Cincinnati Bell in its $650 million combination with Hawaiian Telcom and its $201 million acquisition of OnX Enterprise Solutions;
- Eurazeo in its majority investment in WorldStrides;
- Crown Castle in its $7.1 billion acquisition of Lightower and its $1.5 billion acquisition of FiberNet;
- Alere in its $8 billion sale to Abbott Laboratories;
- MarkWest Energy Partners in its $21 billion merger with MPLX;
- IBM in its acquisition of Clearleap; and
- Olin in its $5 billion Reverse Morris Trust acquisition of the chlorine value chain business of Dow Chemical.
Mr. Wark has also represented numerous companies and boards of directors regarding shareholder activism, including representing Benchmark Electronics in its cooperation agreement with Engaged Capital, Corteva in its agreement with Starboard, Sensata Technologies in its cooperation agreement with Elliott Management and ViewRay in its cooperation agreement with Hudson Executive Capital.
Mr. Wark was named an M&A “Rising Star” by The Deal in 2021 and has been recognized by Lawdragon as among the “500 Leading Dealmakers in America” and the “500 X – The Next Generation.” He also co‑authored the United States chapter of “Getting the Deal Through: Distressed M&A.”
Mr. Wark was born in Portland, Oregon. He received a B.S. from Duke University in 2010 and a J.D. from Columbia Law School in 2013, where he was a Harlan Fiske Stone Scholar and a Staff Editor of the Law Review.
Mr. Wark joined Cravath in 2013 and was elected a partner in 2020.
Mr. Wark’s notable M&A transactions include representing:
- Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
- CardWorks in its acquisition of Ally’s credit card business;
- Just Eat Takeaway.com in the sale of Grubhub to Wonder;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
-
Viatris in its divestitures totaling $3.6 billion in value, including the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses;
-
Viatris in its $750 million acquisitions of Oyster Point and Famy Life Sciences;
- Newcrest in its A$28.8 billion acquisition by Newmont;
- FS Investments in its combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
- Cowen in its $1.9 billion acquisition by TD;
- Convey Health Solutions in its $1.1 billion take‑private acquisition by TPG Capital;
- GuideWell in its $900 million combination with Triple-S Management;
- The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;
- Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;
- Barrick Gold in its proposed $42 billion merger and subsequent joint venture with Newmont Mining and its $18.3 billion merger with Randgold Resources;
- RELX Group in its acquisition of Emailage;
- Peabody Energy in its proposed joint venture with Arch Resources;
- AXA in its $15.3 billion acquisition of XL;
- Cincinnati Bell in its $650 million combination with Hawaiian Telcom and its $201 million acquisition of OnX Enterprise Solutions;
- Eurazeo in its majority investment in WorldStrides;
- Crown Castle in its $7.1 billion acquisition of Lightower and its $1.5 billion acquisition of FiberNet;
- Alere in its $8 billion sale to Abbott Laboratories;
- MarkWest Energy Partners in its $21 billion merger with MPLX;
- IBM in its acquisition of Clearleap; and
- Olin in its $5 billion Reverse Morris Trust acquisition of the chlorine value chain business of Dow Chemical.
Mr. Wark has also represented numerous companies and boards of directors regarding shareholder activism, including representing Benchmark Electronics in its cooperation agreement with Engaged Capital, Corteva in its agreement with Starboard, Sensata Technologies in its cooperation agreement with Elliott Management and ViewRay in its cooperation agreement with Hudson Executive Capital.
Mr. Wark was named an M&A “Rising Star” by The Deal in 2021 and has been recognized by Lawdragon as among the “500 Leading Dealmakers in America” and the “500 X – The Next Generation.” He also co‑authored the United States chapter of “Getting the Deal Through: Distressed M&A.”
Mr. Wark was born in Portland, Oregon. He received a B.S. from Duke University in 2010 and a J.D. from Columbia Law School in 2013, where he was a Harlan Fiske Stone Scholar and a Staff Editor of the Law Review.
Mr. Wark joined Cravath in 2013 and was elected a partner in 2020.
Education
- J.D., 2013, Columbia Law SchoolHarlan Fiske Stone Scholar
- B.S., 2010, Duke University
Admitted In
- New York
Rankings
The Dealmaker Quarterly
- Rising Star (2021)
Lawdragon
- 500 Leading Dealmakers in America (2024, 2023)
- 500 X – The Next Generation (2024, 2023)
Deals & Cases
January 28, 2025
Paragon 28’s $1.2 Billion Acquisition by Zimmer Biomet
On January 28, 2025, Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused on the foot and ankle orthopedic segment, and Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”), a global medical technology leader, announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. Cravath is representing Paragon 28 in connection with the transaction.
Deals & Cases
January 22, 2025
CardWorks’s Acquisition of Ally’s Credit Card Business
On January 22, 2025, CardWorks, Inc. (“CardWorks”), a leader in credit and payments, and Ally Financial Inc. (“Ally”), a financial services company with the nation’s largest all‑digital bank and an industry‑leading auto financing business, announced that they have entered into a definitive agreement for CardWorks, and its wholly‑owned bank subsidiary, Merrick Bank, to acquire Ally’s credit card business, including a portfolio of $2.3 billion in credit card receivables with 1.3 million active cardholders as of December 31, 2024. Cravath is representing CardWorks in connection with the transaction.
Deals & Cases
November 13, 2024
Just Eat Takeaway.com’s Sale of Grubhub to Wonder
On November 13, 2024, Just Eat Takeaway.com N.V. (“Just Eat Takeaway.com”), one of the world’s leading global online food delivery companies, announced that it has entered into a definitive agreement to sell Grubhub Inc. (“Grubhub”) to Wonder Group, Inc. (“Wonder”) for an enterprise value of $650 million. Grubhub will be transferred with its $500 million of senior notes. Cravath is representing Just Eat Takeaway.com in connection with the transaction.
Deals & Cases
July 16, 2024
Atalaya Capital Management’s Sale of its Business to Blue Owl Capital
On July 16, 2024, Atalaya Capital Management LP (“Atalaya Capital Management”), a privately‑held alternative credit manager, and Blue Owl Capital Inc. (“Blue Owl Capital”), an alternative asset manager, announced that they have entered into a definitive agreement for Blue Owl Capital to acquire the business of Atalaya Capital Management for $450 million. The closing purchase price of $450 million is comprised of $350 million of Blue Owl equity and $100 million of cash. In addition, there is potential for up to $350 million of earnout consideration in the form of equity, subject to certain adjustments and achievement of future revenue targets. Cravath is representing Atalaya Capital Management in connection with the transaction.
Deals & Cases
April 30, 2024
Sensata Technologies’ Cooperation Agreement with Elliott
On April 29, 2024, Sensata Technologies Holding plc (“Sensata Technologies”), a global industrial technology company, announced that it has entered into a Cooperation Agreement with Elliott Investment Management L.P. (“Elliott”). The Cooperation Agreement contains customary standstill, voting and other provisions. Cravath is representing Sensata Technologies in connection with the agreement.
Activities
June 12, 2024
Three Cravath Partners Featured in Vault’s 2024 Guide to Legal Practice Areas
Cravath partners Helam Gebremariam, Evan Norris and Andrew M. Wark were featured in the 2024 edition of “Practice Perspectives: Vault’s Guide to Legal Practice Areas,” which highlights the experiences of practicing lawyers in more than 20 different areas of the law and is published annually.
Publications
October 24, 2023
SEC Adopts Rule Amendments To Modernize Beneficial Ownership Reporting
On October 20, 2023, Cravath prepared a memo for its clients entitled “SEC Adopts Rule Amendments To Modernize Beneficial Ownership Reporting.” The memo examines the U.S. Securities and Exchange Commission’s recently adopted final rule amendments to modernize beneficial ownership reporting under Sections 13(d) and 13(g) of the Securities Exchange Act of 1934. The memo outlines the final rule amendments’ changes and guidance related to deadlines and cut‑off times for Schedule 13D and Schedule 13G filings, structured data language, the application of Regulation 13D-G to certain derivative securities and the definition of “group” in existing statutory language.
Publications
March 17, 2023
Andrew Wark and Maggie Segall Author Chapter on U.S. Antitrust Enforcement Trends in Deal‑Making for the International Comparative Legal Guide’s “Mergers & Acquisitions 2023”
Cravath partners Andrew M. Wark and Margaret T. Segall authored a chapter for the International Comparative Legal Guide’s “Mergers & Acquisitions 2023,” which provides cross border insights into mergers and acquisitions and was published by Global Legal Group on March 16, 2023. The chapter, entitled “Key Drivers and Trends: Deal‑Making in an Era of Heightened Antitrust Enforcement,” examines how companies considering M&A transactions in the United States have faced an evolving antitrust landscape, including changed enforcement practices and merger review procedures.
Publications
December 01, 2022
Jed Zobitz, Paul Zumbro and Andrew Wark Co‑Author U.S. Chapter of Lexology Getting The Deal Through’s “Distressed M&A 2023”
Cravath partners George E. Zobitz, Paul H. Zumbro and Andrew M. Wark co‑authored the United States chapter of Lexology Getting The Deal Through’s “Distressed M&A 2023,” which was published in November 2022. The chapter surveys the current market climate and legal framework for distressed M&A and provides a comprehensive overview of these transactions. The authors address relevant considerations involving transaction structures and sale process, due diligence, valuation and financing, documentation, regulatory and judicial approvals, and dispute resolution.
Cravath Bicentennial
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.